Multiple Sclerosis

Latest News

cartoon of man in wheelchair with drawimng of nerve cell | Image credit: ©bsd studio stock.adobe.com
Sanofi’s Tolebrutinib Meets Primary Endpoint in Phase 3 MS Trial

September 3rd 2024

A positive result for Bruton’s tyrosine kinase inhibitor after the drug had ben put on partial clinical hold due to concerns about liver toxicity.

Low to Moderate Alcohol Consumption Associated with Less Disability in Patients with MS, Study Finds
Low to Moderate Alcohol Consumption Associated with Less Disability in Patients with MS, Study Finds

August 14th 2024

Potential First-in-Class M1R Antagonist May Promote Remyelination and Restore Function in Patients with MS
Potential First-in-Class M1R Antagonist May Promote Remyelination and Restore Function in Patients with MS

August 9th 2024

Intranasal Foralumab Receives Fast Track Designation for Nonactive Secondary Progressive MS
Intranasal Foralumab Receives Fast Track Designation for Nonactive Secondary Progressive MS

August 7th 2024

New Study Shows Short-Term Benefits of Stem Cell Therapy for MS Patients, But Long-Term Efficacy Remains Unclear
New Study Shows Short-Term Benefits of Stem Cell Therapy for MS Patients, But Long-Term Efficacy Remains Unclear

July 22nd 2024

Latest CME Events & Activities

Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

View More

More News

Shiny Drug Price

Specialty Medications and Managed Care Pharmacy

Kayt Sukel
October 18th 2019

At AMCP Nexus 2019, experts weigh in on new and emerging specialty medications.

Read More

Neurological disease

What’s New in the MS Drug Pipeline

Jennifer Gershman, PharmD, CPh
August 9th 2019

MS is in need of new medications-these could be the future.

Read More

<12345
© 2024 MJH Life Sciences

All rights reserved.